Work

Chimeric antigen receptor T cell therapy in AML: How close are we?

Year: 2016

Type: article

Source: Best Practice & Research Clinical Haematology

DOI: 10.1016/j.beha.2016.10.004

Author: Saar Gill

Institutions: University of Pennsylvania Health System, University of Pennsylvania

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Chimeric Antigen Receptor T cell Therapy for Acute Myeloid Leukemia (AML)

OpenAlex ID: W2532336496

FWCI: 2.873

Cites: 28

Cited by: 22

Related to: 10